Abstract 15 — Lupus Low Disease Activity State: An Underutilised Clinical Target that is Attainable and Protective against Lupus Nephritis Relapse

Background Lupus nephritis (LN) is a significant comorbidity affecting approximately 50-60% of patients with systemic lupus erythematosus (SLE). Complete and partial renal response (CRR/PRR) have been recommended as treatment targets in LN. Lupus low disease activity state (LLDAS) is also associated...

詳細記述

書誌詳細
主要な著者: Chak Kwan Cheung, Chak Sing Lau, Shirley Chiu Wai Chan
フォーマット: 論文
言語:English
出版事項: World Scientific Publishing 2023-11-01
シリーズ:Journal of Clinical Rheumatology and Immunology
オンライン・アクセス:https://www.worldscientific.com/doi/10.1142/S2661341723740310